bioRxivNeurosciencePreprint
The striatal heterogeneous nuclear ribonucleoprotein H mRNA targetome associated with methamphetamine administration and behavior
Qiu T. RuaniD, William B. Lynch, Rebecca H. Cole, Michael A. RiegeriD, Britahny M. Baskin, Sophia A. MiracleiD, Jacob A. BeierleiD, Emily J. Yao, Jiayi Wu Cox, Amarpreet K. Kandola, Kayla T. Richardson, Melanie M. Chen, Julia C. KelliheriD, R.K. BabbsiD, Peter E.A. AshiD, Benjamin L. WoloziniD, Karen Kathleen SzumlinskiiD, William Evan JohnsoniD, Joseph D. DoughertyiD, Camron D. BryantiD
Abstract
Methamphetamine addiction remains a major public health concern in the United States that has paralleled the opioid epidemic. Psychostimulant use disorders have a heritable genetic component that remains unexplained. Methamphetamine targets membrane and vesicular transporters to increase synaptic dopamine, norepinephrine, and serotonin. We previously identified Hnrnph1 (heterogeneous nuclear ribonucleoprotein H1) as a quantitative trait gene underlying methamphetamine behavioral sensitivity. Hnrnph1 encodes the RNA-binding protein hnRNP H1 that is ubiquitously expressed in neurons throughout the brain. Gene-edited mice with a heterozygous frameshift deletion in Hnrnph1s first coding exon of showed reduced methamphetamine-induced dopamine release and behaviors. To inform the mechanism linking hnRNP H with methamphetamine neurobehavioral effects, we surveyed the mRNA targetome of hnRNP H via cross-linking immunoprecipitation coupled with RNA-sequencing in striatal tissue at baseline and at 30 min post-methamphetamine in wild-type male and female C57BL/6J mice. Methamphetamine induced changes in RNA-binding targets of hnRNP H in mice, including differential binding to 3UTR targets and multiple enriched mRNAs involved in synaptic plasticity. Targetome, transcriptome, and spliceome analyses triangulated on Cacna2d2 as a suggestive target, with differences in hnRNP H binding, gene expression and splicing following methamphetamine treatment (2 mg/kg, i.p.). Furthermore, pre-treatment with pregabalin, an inhibitor of 2{delta}2 and 2{delta}1 voltage-gated calcium channel subunits, attenuated methamphetamine-induced locomotor activity in male and female mice, supporting a role for Cacna2d1/d2 in methamphetamine locomotor stimulant sensitivity. Our study identifies a dynamic hnRNP H RNA targetome that can rapidly and adaptively respond to methamphetamine to regulate gene expression and likely synaptic plasticity and behavior.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A mutation in Hnrnph1 that decreases methamphetamine-induced reinforcement, reward, and dopamine release and increases synaptosomal hnRNP H and mitochondrial proteins
Qiu T. Ruan, Neema Yazdani, … Camron D. Bryant·Journal of NeurosciencePeer-reviewed·Nov 8, 2019
- Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation
Qiu T. Ruan, Neema Yazdani, … Camron D. Bryant·Neuroscience LettersPeer-reviewed·Jul 9, 2018
- 5' UTR variants in the quantitative trait gene Hnrnph1 support reduced 5' UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity
Qiu T. Ruan, Neema Yazdani, … Camron D. Bryant·The FASEB JournalPeer-reviewed·May 13, 2020
- Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice
Kristyn N. Borrelli, Carly R. Langan, … Camron D. Bryant·PsychopharmacologyPeer-reviewed·Mar 23, 2021
- Fentanyl-induced antinociception, reward, reinforcement, and withdrawal in Hnrnph1 mutant mice
Camron D. Bryant, Aidan F. Healy, … Karen Kathleen Szumlinski·bioRxiv·Jun 6, 2020
- Cell-type specific transcriptional adaptations of nucleus accumbens interneurons to amphetamine
David A. Gallegos, Melyssa S. Minto, … Anne E. West·Molecular PsychiatryPeer-reviewed·Feb 16, 2022